Impact of Sex on the Efficacy and Safety of Panitumumab Plus Fluorouracil and Folinic Acid as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)
ESMO Open 2023 Aug 01;8(4)101568, K Heinrich, M Karthaus, S Fruehauf, U Graeven, L Mueller, AO König, LF von Weikersthal, K Caca, A Kretzschmar, E Goekkurt, S Haas, AHS Alig, A Kurreck, A Stahler, S Held, G Sommerhäuser, V Heinemann, S Stintzing, T Trarbach, DP ModestFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.